证券代码：000566 证券简称：海南海药 公告编号：2025-061 海南海药股份有限公司 关于持股 5%以上股东部分股份被司法拍卖的进展公告 公司将持续关注本次拍卖事项的进展情况，并按照相关规定及时履行信息披 露义务。 1 特此公告 海南海药股份有限公司 董 事 会 二〇二五年十月十七日 2 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 海南海药股份有限公司（以下简称"公司"或"海南海药"）于 2025 年 10 月 9 日、10 月 16 日在巨潮资讯网（http//www.cninfo.com.cn）披露了《关于 持股 5%以上股东部分股份被司法拍卖的提示性公告》（公告编号：2025-059） 和《关于持股5%以上股东部分股份被司法拍卖的进展公告》（公告编号：2025-060）， 湖北省武汉市中级人民法院（以下简称"武汉中院"）在京东网进行公开司法拍 卖深圳市南方同正投资有限公司（以下简称"南方同正"）所持海南海药已质押 的 130,825,900 股股票。2025 年 10 月 15 日，武汉中院提示"执行异议中，需 修改公告内容"，暂缓拍卖。20 ...

Group 1 - The Hainan Free Trade Zone concept rose by 2.58%, ranking first among concept sectors, with 22 stocks increasing, including Haixia Co., Haima Automobile, and ST Huawen hitting the daily limit [1][2] - Notable gainers included Haikou Group, Hainan Haiyao, and Kangzhi Pharmaceutical, which rose by 6.38%, 6.14%, and 5.69% respectively [1] - The stocks with the largest declines were Hainan Huatie, Junda Co., and *ST Shuangcheng, which fell by 1.30%, 1.23%, and 1.06% respectively [1] Group 2 - The Hainan Free Trade Zone concept saw a net inflow of 358 million yuan from main funds, with 18 stocks receiving net inflows, and 6 stocks exceeding 50 million yuan [2] - The top net inflow stock was Haixia Co., with a net inflow of 108 million yuan, followed by HNA Holding, Hainan Development, and Haide Co. with net inflows of 89.09 million yuan, 82.73 million yuan, and 64.19 million yuan respectively [2][3] - The highest net inflow ratios were seen in Haide Co., ST Huawen, and Hainan Haiyao, with ratios of 14.30%, 13.37%, and 12.49% respectively [3] Group 3 - The top stocks in the Hainan Free Trade Zone concept included Haixia Co. with a daily increase of 10.03% and a turnover rate of 6.55%, followed by HNA Holding with a 1.80% increase and a turnover rate of 2.30% [3][4] - Other notable performers included Hainan Development with a 2.99% increase and a turnover rate of 8.46%, and Haikou Group with a 6.38% increase and a turnover rate of 7.54% [4] - Stocks such as Hainan Huatie and Junda Co. experienced declines of 1.30% and 1.23% respectively, with negative main fund flows [4]

海南海药股份有限公司 关于持股 5%以上股东部分股份被司法拍卖的进展公告 证券代码：000566 证券简称：海南海药 公告编号：2025-060 公司将持续关注拍卖平台及法院的公告，及时披露进展情况。公司指定的信 息披露媒体为《上海证券报》《证券日报》和巨潮资讯网（www.cninfo.com.cn）， 有关公司信息均以在上述指定媒体刊登的信息为准。敬请广大投资者关注公司公 告，注意投资风险。 特此公告 海南海药股份有限公司 董 事 会 1 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 海南海药股份有限公司（以下简称"公司"或"海南海药"）于 2025 年 10 月 9 日在巨潮资讯网（http//www.cninfo.com.cn）披露了《关于持股 5%以上股 东部分股份被司法拍卖的提示性公告》（公告编号：2025-059）。湖北省武汉市 中级人民法院（以下简称"武汉中院"）分别拟于 2025 年 10 月 15 日 10 时至 2025 年 10 月 16 日 10 时止（延时除外）及 2025 年 11 月 6 日 10 时至 2025 年 11 月 ...

Core Viewpoint - Hainan Haiyao (Shenzhen Stock Code: 000566) announced that due to a contractual dispute, a portion of shares held by its shareholder, Shenzhen Nanfang Tongzheng Investment Co., Ltd. ("Nanfang Tongzheng"), will be subject to judicial auction, with significant implications for the company's ownership structure and financial health [2][4]. Group 1: Judicial Auction Details - The Wuhan Intermediate People's Court plans to publicly auction 131 million shares of Hainan Haiyao, which represents 98.11% of Nanfang Tongzheng's total holdings and 10.08% of the company's total share capital, on October 15-16, 2025, and November 6-7, 2025 [2][3]. - Nanfang Tongzheng is currently the second-largest shareholder of Hainan Haiyao, holding 133 million shares, which accounts for 10.28% of the total share capital, all of which are pledged and frozen [3]. Group 2: Company Financial Performance - Hainan Haiyao has been facing significant financial losses, with net profits attributed to shareholders projected at -106 million yuan for 2023 and -1.525 billion yuan for 2024. In the first half of 2025, the company reported revenues of 450 million yuan, a year-on-year decrease of 24.12%, and a net profit of -158 million yuan, an increase in loss of 20.97% year-on-year [4]. - The company's stock price increased by 1.48% to 5.50 yuan per share as of September 30, 2023, with a total market capitalization of 7.136 billion yuan [5].

Performance Disclosure - Yonghe Co. expects a net profit attributable to shareholders of 456 million to 476 million yuan for the first three quarters of 2025, representing a year-on-year increase of 211.59% to 225.25% [1] - Chipone Technology anticipates a third-quarter revenue of 1.284 billion yuan, marking a historical high for the company with a quarter-on-quarter increase of 119.74% and a year-on-year growth of 78.77% [2] Sales Performance - BYD reported a year-on-year decline of 5.52% in new energy vehicle sales for September, with total sales of 396,300 units [3] - Seres announced a year-on-year increase of 19.44% in new energy vehicle sales for September, totaling 44,700 units, with cumulative sales of 304,600 units from January to September [4] Shareholding Changes - Dihun Network's controlling shareholder, Hu Jianping, completed a reduction of 2% of the company's shares, totaling 4.8692 million shares [5] - Ruile New Materials announced that a major shareholder plans to reduce their holdings by no more than 10,800 shares, which is 0.0581% of the total share capital [6] - Huaxing Yuanchuang's employee stock ownership platform plans to reduce its holdings by up to 4 million shares, accounting for 0.9% of the total share capital [7] Risk Matters - ST Gaohong received a notice of termination of listing from the Shenzhen Stock Exchange, indicating a potential end to the company's stock trading [8] - Suihengyun A expects losses from the impact of Typhoon "Hagupit" to exceed 10% of the company's net profit for 2024 due to damage to assets in a photovoltaic project [9] - Hainan Haiyao announced that approximately 131 million shares held by a major shareholder will be subject to judicial auction, representing 10.08% of the total share capital [10]

Performance Disclosure - Yonghe Co., Ltd. expects a year-on-year increase in net profit attributable to shareholders of 211.59% to 225.25%, with an estimated profit of 456 million to 476 million yuan for the first three quarters of 2025 [1] - Chip Original Co., Ltd. anticipates a 78.77% year-on-year increase in revenue for the third quarter of 2025, projecting a revenue of 1.284 billion yuan, marking a significant quarter-on-quarter growth of 119.74% [2] Sales Performance - BYD reported a 5.52% year-on-year decline in new energy vehicle sales in September, with sales reaching 396,300 units [3] - Seres Co., Ltd. experienced a 19.44% year-on-year increase in new energy vehicle sales in September, achieving sales of 44,700 units, with cumulative sales of 304,600 units from January to September [4] Shareholding Changes - Dihun Network's controlling shareholder, Hu Jianping, completed a 2% reduction in company shares, totaling 4.8692 million shares [5] - Ruian New Materials announced that a major shareholder plans to reduce their holdings by no more than 0.0581% of the company's total shares, equating to approximately 100,800 shares [6] - Huaxing Yuanchuang's employee stock ownership platform plans to reduce its holdings by up to 0.9% of the company's total shares, amounting to a maximum of 4 million shares [7] Risk Events - *ST Gaohong received a notice of termination of listing from the Shenzhen Stock Exchange, indicating a potential end to the company's stock trading [8] - Suihengyun A expects losses from a typhoon disaster to exceed 10% of the company's projected net profit for 2024, affecting assets in a photovoltaic project [9] - Hainan Haiyao announced that approximately 131 million shares held by a major shareholder will be subject to judicial auction, representing 98.11% of their holdings and 10.08% of the company's total shares [10]

Core Viewpoint - Hainan Haiyao (000566.SZ) announced a judicial auction involving 130,825,900 shares pledged by its major shareholder, Shenzhen Nanfang Tongzheng Investment Co., Ltd, which represents 98.11% of their total holdings and 10.08% of the company's total share capital [1] Group 1 - The judicial auction will take place in two phases: the second auction involves 123,825,900 shares scheduled for October 15-16, 2025, while the first auction involves 7,000,000 shares set for November 6-7, 2025 [1] - If all shares are successfully auctioned, Nanfang Tongzheng's holdings in the company will decrease to 2,520,418 shares, representing 0.19% of the total share capital [1]

Core Viewpoint - Hainan Haiyao announced that its major shareholder, Southern Tongzheng, will auction off 130,825,900 pledged shares, representing 98.11% of its holdings and 10.08% of the company's total shares [1] Summary by Sections - **Shareholder Actions** - Southern Tongzheng will auction 130,825,900 shares, with 123,825,900 shares scheduled for a second auction on October 15-16, 2025, and 7,000,000 shares for a first auction on November 6-7, 2025 [1] - If the auctions are successful, Southern Tongzheng's holdings will decrease to 2,520,418 shares, representing 0.19% of the total [1] - **Impact on Company Control** - The auction will not affect the company's control and operations as Southern Tongzheng is neither the controlling shareholder nor the actual controller [1] - **Current Status** - The auction is currently in the public notice phase, and the outcome remains uncertain, with the company committed to disclosing further developments [1]

关于持股 5%以上股东部分股份被司法拍卖的提示性公告 本公司董事会及全体董事保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 重要内容提示： 1、本次司法拍卖标的为公司持股 5%以上股东深圳市南方同正投资有限公司 （以下简称"南方同正"）所持海南海药股份有限公司（以下简称"公司"或"海 南海药"）已质押的 130,825,900 股股票，占其所持公司全部股份的 98.11%， 占公司总股本的 10.08%。其中涉及第二次拍卖的股份 123,825,900 股拟于 2025 年 10 月 15 日 10 时至 2025 年 10 月 16 日 10 时止（延时除外）进行公开司法拍 卖，涉及首次拍卖的股份 7,000,000 股拟于 2025 年 11 月 6 日 10 时至 2025 年 11 月 7 日 10 时止（延时除外）进行公开司法拍卖。如上述所涉司法拍卖股份全 部拍卖成功，南方同正持有公司的股份将减少至 2,520,418 股，占公司总股本的 0.19%。 2、南方同正不属于公司控股股东、实际控制人，本次拍卖事项不会导致公 司实际控制权变更，亦不会对公司生产、经营造成不利影响。 ...

Core Viewpoint - Hainan Haiyao's stock price has shown fluctuations with a year-to-date increase of 15.45%, but recent trends indicate a decline over the past 5, 20, and 60 days [1][2] Company Overview - Hainan Haiyao Co., Ltd. is located in Haikou, Hainan Province, and was established on December 30, 1992, with its stock listed on May 25, 1994 [1] - The company specializes in traditional and Western medicine, fine chemical products, chemical raw materials, health products, and related import-export trade [1] - The revenue composition includes: Other varieties 29.93%, Gastrointestinal health 25.07%, Medical services 18.60%, Raw materials and intermediates 13.27%, Cephalosporin series 10.19%, Others (supplement) 2.95% [1] Financial Performance - For the first half of 2025, Hainan Haiyao reported revenue of 450 million yuan, a year-on-year decrease of 24.12%, while the net profit attributable to shareholders was -158 million yuan, an increase of 20.97% year-on-year [2] - The company has cumulatively distributed 466 million yuan in dividends since its A-share listing, with no distributions in the past three years [3] Shareholder Information - As of September 20, 2025, the number of shareholders is 74,900, a decrease of 1.86% from the previous period, with an average of 15,560 circulating shares per person, an increase of 1.89% [2] - Notable institutional shareholders include: - GF Healthcare Stock A (004851) as the fifth largest shareholder with 11.73 million shares, a new entry - Hong Kong Central Clearing Limited as the seventh largest shareholder with 7.79 million shares, an increase of 2.40 million shares from the previous period - Huaan Contrarian Strategy Mixed A (040035) as the ninth largest shareholder with 6.01 million shares, also a new entry [3]